121 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
supplementary schedules and information.
Attend Board and Subcommittee meetings (as warranted), including being the lead staff on the Audit and Risk … and pension plan requirements, as well as financial statements and cash flow projections for use by Executive management, as well as the Audit and Risk
S-8
EX-23.1
aium6u52vhbo
21 Dec 23
Registration of securities for employees
7:22pm
424B3
o9ib7zu6s3x ybpq48
13 Nov 23
Prospectus supplement
5:05pm
8-K
EX-10.1
fo8uw k02
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.2
v30 tnkzac
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm